EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 78.87
-0.13 (-0.16%)
At close: Apr 24, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 2.30 billion as of April 25, 2025. Its market cap has increased by 82.87% in one year.
Market Cap
2.30B
Enterprise Value
2.44B
Revenue
338.39M
Ranking
n/a
PE Ratio
66.36
Stock Price
78.87
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 2.30B, an increase of 2,835.26%. That is a compound annual growth rate of 34.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 91.15B |
| Sectra AB | 52.29B |
| Getinge AB | 49.98B |
| Camurus AB | 32.96B |
| Medicover AB | 31.53B |
| Vitrolife AB | 20.65B |
| Bonesupport Holding AB | 20.50B |
| AddLife AB | 18.68B |